Comparison of new and classical point mutations associated with clarithromycin resistance in Helicobacter pylori strains isolated from dyspeptic patients and their effects on phenotypic clarithromycin resistance-Reference-Cited by-同舟云学术

Comparison of new and classical point mutations associated with clarithromycin resistance in Helicobacter pylori strains isolated from dyspeptic patients and their effects on phenotypic clarithromycin resistance

Published:2019-04-01 Issue:4 Volume:68 Page:566-573
ISSN:0022-2615
Container-title:Journal of Medical Microbiology
language:en
Short-container-title:

Author:

Kocazeybek Bekir¹^ORCID,Sakli Merve Kutlu¹,Yuksel Pelin¹,Demirci Mehmet²^ORCID,Caliskan Reyhan¹,Sarp Tevhide Ziver³,Saribas Suat¹^ORCID,Demiryas Suleyman⁴^ORCID,Kalayci Fatma¹^ORCID,Cakan Huseyin⁵,Uysal Hayriye Kirkoyun⁶,Gareayaghi Nesrin⁷,Ergin Sevgi¹,Erzin Yusuf Ziya⁸,Bal Kadir⁸,Tascı İhsan⁴,Tokman Hrisi Bahar¹

Affiliation:

1. Department of Medical Microbiology, Cerrahpasa Faculty of Medicine, Istanbul University – Cerrahpasa, Istanbul, Turkey

2. Beykent University Medical Faculty, Department of Medical Microbiology, Istanbul, Turkey

3. Eastern Mediterranean University, Faculty of Health Sciences, Nutrition and Dietetic Department, Famagusta, North Cyprus

4. Department of General Surgery, Cerrahpasa Faculty of Medicine, Istanbul University – Cerrahpasa, Istanbul, Turkey

5. Department of Microbiology, Istanbul University-Cerrahpasa, Institute of Forensic Sciences, Istanbul, Turkey

6. Istanbul University, Istanbul Medical Faculty, Department of Medical Microbiology, Istanbul, Turkey

7. Istanbul Sisli Hamidiye Etfal Training and Research Hospita, Blood Center, Istanbul, Turkey

8. Department of Gastroenterology, Cerrahpasa Medical Faculty, Istanbul University – Cerrahpasa, Istanbul, Turkey

Publisher

Microbiology Society

Subject

Microbiology (medical),General Medicine,Microbiology

Reference29 articles.

1. Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis

2. Helicobacter pyloriInfection and the Risk of Gastric Carcinoma

3. Seven days triple therapy for eradication of Helicobacter pylori does not alter the disease activity of patients with inflammatory bowel disease

4. Optimal therapy for Helicobacter pylori infections

5. Helicobacter pylori treatment in the era of increasing antibiotic resistance

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evidence of Helicobacter pylori heterogeneity in human stomachs by susceptibility testing and characterization of mutations in drug-resistant isolates;Scientific Reports;2024-05-27

2. Role of MIC levels and 23S rRNA mutation sites to clarithromycin in 14-day clarithromycin bismuth quadruple therapy for Helicobacter pylori eradication: A prospective trial in Beijing;Heliyon;2024-04

3. High antibiotic resistance rates in Helicobacter pylori strains in Turkey over 20 years: implications for gastric disease treatment;European Journal of Gastroenterology & Hepatology;2024-03-25

4. A comprehensive study of Helicobacter pylori infection: molecular analysis, antibacterial susceptibility, and histopathological examination;Antonie van Leeuwenhoek;2023-08-21

5. Molecular Characterization of Clarithromycin Resistance in Helicobacter pylori Strains;The Turkish Journal of Gastroenterology;2023-04-19